These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the concept of targeting ACKR3 as a singular method to modulate the opioid system, which could open up new therapeutic avenues for opioid-related disorders. By ticking this box https://richardn504iie6.blogozz.com/profile